Minerva Neurosciences, Inc. — Investor Relations & Filings
Filings indexed
589
across all filing types
Latest filing
2026-05-27
Regulatory Filings
Country
US
United States of America
Listing
US
NERV
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of product candidates for the treatment of central nervous system (CNS) diseases. The company's lead product candidate is roluperidone, which is being developed to treat the negative symptoms of schizophrenia. Minerva Neurosciences leverages its expertise in clinical development to design innovative trials with clinical endpoints aimed at demonstrating direct patient benefit.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-27 | English | |
| 424B5 | 2026-05-27 | English | |
| 10-Q - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-05-05 | English | |
| 8-K - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-05-05 | English | |
| ARS - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-04-23 | English | |
| DEF 14A - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-04-23 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47845662 | 8-K | 2026-05-27 | English | ||
| 47845919 | 424B5 | 2026-05-27 | English | ||
| 41373781 | 10-Q - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-05-05 | English | ||
| 41366414 | 8-K - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-05-05 | English | ||
| 35695380 | ARS - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-04-23 | English | ||
| 35694016 | DEF 14A - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-04-23 | English | ||
| 33644856 | 8-K - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-04-06 | English | ||
| 32997937 | EFFECT - Minerva Neurosciences, Inc. (0001598646) (Filer) | 2026-03-20 | English | ||
| 30823528 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 30823514 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 30823505 | SCHEDULE 13G Filing | 2026-02-12 | English | ||
| 30823508 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 30823520 | 8-K Filing | 2026-02-03 | English | ||
| 12747695 | Regulatory Filings 2026 | 2026-01-07 | English | ||
| 12747696 | 424B3 | 2026-01-06 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
|
Adaptogenics Health Corp.
Formulates and distributes functional mushroom and adaptoge…
|
ADPT | CA | Manufacturing |
|
Adastra Holdings
Manufacturer and supplier of ethnobotanical and processed c…
|
XTRX | CA | Manufacturing |
|
ADBIOTECH Co.,Ltd.
Develops IgY-based immune antibodies as alternatives to vac…
|
179530 | KR | Manufacturing |
|
ADC Therapeutics SA
Commercial-stage biotech developing antibody-drug conjugate…
|
ADCT | US | Manufacturing |
|
Addex Therapeutics Ltd.
Clinical-stage biopharma developing allosteric modulators f…
|
ADXN | CH | Manufacturing |
|
Adeshwar Meditex Limited
Manufacturer and exporter of medical disposables, surgical …
|
543309 | IN | Manufacturing |
|
ADIAL PHARMACEUTICALS, INC.
A clinical-stage biopharma developing genetically targeted …
|
ADIL | US | Manufacturing |
|
Adicet Bio, Inc.
Develops allogeneic gamma delta T cell therapies for cancer…
|
ACET | US | Manufacturing |
|
ADIM
Develops and manufactures human vaccines and biologics for …
|
4142 | TW | Manufacturing |
Minerva Neurosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35086/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35086 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35086 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35086 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35086}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Minerva Neurosciences, Inc. (id: 35086)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.